PTC Therapeutics -- PTCT Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PTC Therapeutics -- PTCT

PTCT 68.30

+0.3%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (18)	10/8/2014 2:13:36 PM
From: ghmm	Read Replies (2) of 38

I'm not a fan or hater of Martin actually :-). I think when he was CEO he bought a mixed bag to rtrx (I've never had a position). As far as rtrx programs again I thought a mixed bag. I thought PKAN was interesting though early. I don't have the problem of him working within the system to hike the price especially if he is true to his word (which some may question) and no existing patients lose access to the treatment. What I did find hypercritical is attacking QCOR and then doing basically the same thing. Thanks for the PTC references. I didn't even realize they had a Hep-C program. Since I am on the fence with whether or not their DMD works to me the SMA program is what I find most interesting. Do you have any thoughts one way or the other on it? TIA

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next